Related Experiment Video
Updated: Jul 3, 2026
09:03
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Cerebropulmonary dysgenetic syndrome.
D Radford Shanklin1, Amanda C Mullins, Heather S Baldwin
1Department of Pathology and Laboratory Medicine, University of Tennessee, Memphis 38163, USA. dshanklin@utmem.edu
Experimental and Molecular Pathology
|July 8, 2008
Summary
A novel genetic disorder, cerebropulmonary dysgenetic syndrome, is identified, linked to ABCA3 mutations. This condition causes severe lung disease and brain malformations in newborns, previously unreported.
Area of Science:
- Neonatal pathology
- Genetics
- Developmental biology
Background:
- Bronchopulmonary dysplasia, a complication of neonatal respiratory distress treatment, is often linked to ABCA3 transporter protein mutations.
- The co-occurrence of bronchopulmonary dysplasia with severe neurological disorders in premature infants has not been previously documented.
Observation:
- A neonatal autopsy revealed severe interstitial pulmonary fibrosis and cerebral dystrophy in an infant with a heterozygous ABCA3 mutation (p.E292V).
- Review of 1300 neonatal autopsies identified four similar cases and eight with partial findings, suggesting a distinct syndrome.
Findings:
- The identified cases exhibit a consistent pattern of severe pulmonary fibrosis and significant cerebral cortex and cerebellum malformations.
- Genetic analysis in one case confirmed an ABCA3 mutation, supporting its role in the observed pathology.
Implications:
- This study proposes a new disorder, the cerebropulmonary dysgenetic syndrome, characterized by specific pulmonary and neurological defects.
- Understanding this syndrome may lead to improved diagnosis and management of affected newborns.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...